Skip to content

Abscint: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

Abscint

BE 0749.828.410
NACE 86.910, Medical imaging and medical laboratories
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€363,834
2024 · -€1.3m+€1.7m
Equity
€5.6m
2024 · €3.5m+€2.1m
Cash
€2.8m
2024 · €2.1m+€631,844
Balance sheet total
€6.8m
2024 · €4.3m+€2.6m

Largest movements

2024 to 2025
Assets
  • Intangible fixed assets +€1.6m

    up €1.6m (+82.0%), from €1.9m to €3.5m

  • Cash +€631,844

    up €631,844 (+29.4%), from €2.1m to €2.8m

    mainly Contributions, distributions and other (+€1.7m) and Net result for the year (+€363,834)

  • Receivables within one year +€379,134

    up €379,134 (+198%), from €191,537 to €570,670

    of which Other amounts receivable: +€378,380

Equity and liabilities
  • Contributions +€1.1m

    up €1.1m (+17.0%), from €6.2m to €7.2m

  • Investment grants +€672,569

    up €672,569 (+205%), from €327,729 to €1.0m

  • Profit (loss) carried forward +€363,834

    up €363,834 (+11.9%), from -€3.1m to -€2.7m

  • Other debts -€355,708

    down €355,708 (-99.8%), from €356,534 to €826

  • Current portion of long-term debt +€350,000

    new in 2025: €350,000

Income statement
  • Gross operating margin +€1.5m

    up €1.5m, from -€660,224 to €870,849

  • Depreciation -€427,887

    down €427,887 (-59.3%), from €721,576 to €293,689

  • Financial income -€304,131

    down €304,131 (-81.9%), from €371,553 to €67,422

  • Staff costs -€49,272

    down €49,272 (-13.1%), from €376,742 to €327,470

  • Taxes -€9,345

    down €9,345 (-18.1%), from -€51,489 to -€60,834

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 -€1.3m
Gross operating margin +€1.5m
Staff costs +€49,272
Depreciation +€427,887
Other operating charges -€2,196
Financial income -€304,131
Financial charges -€6,972
Taxes +€9,345
Result 2025 €363,834
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€133,802
Investment -€1.9m
Financing +€2.4m
Cash 2024 €2.1m
Net result for the year +€363,834
Depreciation +€293,689
Receivables within one year -€379,134
Deferred charges and accrued income +€6,563
Trade debts +€218,556
Tax, wage and social debts -€13,998
Other debts -€355,708
Investment in fixed assets (net) -€1.9m
Debts after one year +€288,244
Current portion of long-term debt +€350,000
Contributions, distributions and other +€1.7m
Cash 2025 €2.8m
brings cash intakes cash out
Every line side by side 46 lines
Line Code 2024 2025 Change %
Total assets 20/58 €4,272,401 €6,849,261 +€2.6m +60.3%
Formation expenses 20 €0 €2,169 +€2,169
Fixed assets 21/28 €1,923,136 €3,493,413 +€1.6m +81.7%
Intangible fixed assets 21 €1,917,912 €3,490,590 +€1.6m +82.0%
Tangible fixed assets 22/27 €3,964 €1,563 -€2,400 -60.6%
Plant, machinery and equipment 23 €2,375 €1,255 -€1,119 -47.1%
Furniture and vehicles 24 €1,589 €308 -€1,281 -80.6%
Financial fixed assets 28 €1,260 €1,260 = 0.0%
Current assets 29/58 €2,349,265 €3,353,679 +€1.0m +42.8%
Amounts receivable within one year 40/41 €191,537 €570,670 +€379,134 +198%
Trade receivables 40 €2,678 €3,431 +€753 +28.1%
Other amounts receivable 41 €188,859 €567,239 +€378,380 +200%
Cash at bank and in hand 54/58 €2,149,043 €2,780,888 +€631,844 +29.4%
Deferred charges and accrued income 490/1 €8,685 €2,121 -€6,563 -75.6%
Total equity and liabilities 10/49 €4,272,401 €6,849,261 +€2.6m +60.3%
Equity 10/15 €3,467,984 €5,557,750 +€2.1m +60.3%
Contributions 10/11 €6,194,974 €7,248,337 +€1.1m +17.0%
Capital 10 €6,194,974 €7,248,337 +€1.1m +17.0%
Issued capital 100 €6,194,974 €7,248,337 +€1.1m +17.0%
Profit (loss) carried forward 14 -€3,054,719 -€2,690,885 +€363,834 +11.9%
Investment grants 15 €327,729 €1,000,298 +€672,569 +205%
Amounts payable 17/49 €804,417 €1,291,511 +€487,094 +60.6%
Amounts payable after more than one year 17 €140,455 €428,699 +€288,244 +205%
Financial debts 170/4 €140,455 €428,699 +€288,244 +205%
Amounts payable within one year 42/48 €663,962 €862,811 +€198,850 +29.9%
Current portion of amounts payable after more than one year 42 - €350,000 +€350,000
Trade debts 44 €264,736 €483,292 +€218,556 +82.6%
Suppliers 440/4 €264,736 €483,292 +€218,556 +82.6%
Taxes, remuneration and social security 45 €42,692 €28,693 -€13,998 -32.8%
Remuneration and social security 454/9 €42,692 €28,693 -€13,998 -32.8%
Other amounts payable 47/48 €356,534 €826 -€355,708 -99.8%
Non-recurring operating income 76A - €1,250,000 +€1.3m
Remuneration, social security and pensions 62 €376,742 €327,470 -€49,272 -13.1%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €721,576 €293,689 -€427,887 -59.3%
Other operating charges 640/8 €0 €2,196 +€2,196
Non-recurring operating charges 66A €0 - =
Gross operating margin 9900 -€660,224 €870,849 +€1.5m
Operating profit (loss) 9901 -€1,758,542 €247,495 +€2.0m
Financial income 75/76B €371,553 €67,422 -€304,131 -81.9%
Recurring financial income 75 €371,553 €67,422 -€304,131 -81.9%
Financial charges 65/66B €4,946 €11,918 +€6,972 +141%
Recurring financial charges 65 €4,946 €11,918 +€6,972 +141%
Profit (loss) for the period before taxes 9903 -€1,391,935 €302,999 +€1.7m
Income taxes 67/77 -€51,489 -€60,834 -€9,345 -18.1%
Profit (loss) for the period 9904 -€1,340,445 €363,834 +€1.7m
Profit (loss) for the period to be appropriated 9905 -€1,340,445 €363,834 +€1.7m

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 28 October 2026 via checked.be.